StockSelector.com
  Research, Select, & Monitor Friday, September 21, 2018 1:28:12 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Iovance Biotherapeutics, Inc.$13.60($.05)(.37%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Iovance Biotherapeutics, Inc. has an overall rank of 6788 out of 7323 stocks based on 4 positive rankings and 6 negative rankings.

Positive Rankings
Debt-to-Equity
Iovance Biotherapeutics rank is 102
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Iovance Biotherapeutics is ranked 393.
10 Day Gain
Iovance Biotherapeutics rank is 765
Low Put/Call
Iovance Biotherapeutics has a low Put/Call ratio of 0.61 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Iovance Biotherapeutics is ranked 1138.
Negative Rankings
High vPut/Call
Iovance Biotherapeutics has a high Put/Call ratio of 4.02 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Iovance Biotherapeutics is ranked 163.
Down EPS Surprise
Iovance Biotherapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
Negative ROA
Iovance Biotherapeutics rank is 456
Negative ROE
Iovance Biotherapeutics rank is 520
Price-to-Book
Iovance Biotherapeutics rank is 624
90 Day Loss
Iovance Biotherapeutics rank is 1302







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.